Experience of Psychotropic Medication –An Interview Study of Persons with Psychosis

References

• Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry, 67(3), 453-460.
   PubMed Web of Science ®Google Scholar
• Bola, J. R., & Mosher, L. R. (2003). Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project. Journal of Nervous and Mental Disease, 191(4), 219-229. doi: 10.1097 /01.nmd.0000061148.84257.f9
   PubMed Web of Science ®Google Scholar
• Carton, L., Cottencin, O., Lapeyre-Mestre, M., Geoffroy, P. A., Favre, J., Simon, N., & Rolland, B. (2015). Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends. Current Pharmaceutical Design, 21(23), 3280- 3297.
   PubMed Web of Science ®Google Scholar
• Clark, R. E., Bartels, S. J., Mellman, T. A., & Peacock, W. J. (2002). Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophrenia Bulletin, 28(1), 75-84.
   PubMed Web of Science ®Google Scholar
• Cramer, J. A., & Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49(2), 196- 201.
   PubMed Web of Science ®Google Scholar
• Day, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A., Cattell, D., & Power, C. (2005). Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry, 62(7), 717-724. doi: 10.1001 /archpsyc.62.7.717
   PubMed Web of Science ®Google Scholar
• Estroff, S. (1981). Making it crazy. An ethnography of psychiatric clients in an American community. Berkeley: University of California Press.
   Google Scholar
• Gray, R., Rofail, D., Allen, J., & Newey T. (2005). A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing, 52(1), 31–37.
   PubMed Web of Science ®Google Scholar
• Guo, J. J., Wu, J., Kelton, C. M., Jing, Y., Fan, H., Keck, P. E., & Patel, N. C. (2012). Exposure to potentially dangerous drug-drug interactions involving antipsychotics. Psychiatric Services, 63(11), 1080-1088. doi: 10.1176 /appi.ps.201100443
   PubMed Web of Science ®Google Scholar
• Hagen, B., Nixon, G., & Peters T. (2010). The greater of two evils? How people with transformative psychotic experiences view psychotropic medications. Ethical Human Psychology and Psychiatry, 12(1), 44-59.
   Google Scholar
• Hardeman, S. M., Harding, R. K., & Narasimhan, M. (2010). Simplifying adherence in schizophrenia. Psychiatric Services, 61(4), 405-408. doi: 10.1176 /appi.ps.61.4.405
   PubMed Web of Science ®Google Scholar
• Harding, C. M., Brooks, G. W., Ashikaga, T., Strauss, J. S., & Breier, A. (1987). The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144(6), 727-735.
   PubMed Web of Science ®Google Scholar
• Harrow, M., Jobe, T. H., & Faull, R. N. (2012). Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychological Medicine, 42(10), 2145-2155. doi: 10.1017 /s0033291712000220
   PubMed Web of Science ®Google Scholar
• Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry, 172, 413-419.
   PubMed Web of Science ®Google Scholar
• Kirson, N. Y., Weiden, P. J., Yermakov, S., Huang, W., Samuelson, T., Offord, S. J., & Wong, B. J. (2013). Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs. Journal of Clinical Psychiatry, 74(6), 568-575. doi: 10.4088 /JCP.12r08167
   PubMed Web of Science ®Google Scholar
• Lehtinen, V., Aaltonen, J., Koffert, T., Rakkolainen, V., & Syvalahti, E. (2000). Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? European Psychiatry, 15(5), 312-320.
   PubMed Web of Science ®Google Scholar
• Leucht, S., Kissling, W., & Davis, J. M. (2009). Second-generation antipsychotics for schizophrenia: can we resolve the conflict? Psychological Medicine, 39(10), 1591-1602. doi: 10.1017 /s0033291709005455
   PubMed Web of Science ®Google Scholar
• Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353(12), 1209-1223. doi: 10.1056 /NEJMoa051688
   PubMed Web of Science ®Google Scholar
• Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105(3), 164-172.
   PubMed Web of Science ®Google Scholar
• Masand, P. S., Roca, M., Turner, M. S., & Kane, J. M. (2009). Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Primary Care Companion to the Journal of Clinical Psychiatry, 11(4), 147-154. doi: 10.4088 /PCC.08r00612
   PubMedGoogle Scholar
• Mitchell, A. J. (2006). Adherence behaviour with psychotropic medication is a form of self-medication. Medical Hypothesis, 68(1), 12-21.
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., & Cohen, D. (2009). How do psychiatric drugs work?. British Medical Journal, 338, b1963. doi: 10.1136 /bmj.b1963
   PubMed Web of Science ®Google Scholar
• Nose, M., Barbui, C., & Tansella, M. (2003). How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine, 33(7), 1149-1160.
   PubMed Web of Science ®Google Scholar
• Rettenbacher, M. A., Burns, T., Kemmler, G., & Fleischhacker, W. W. (2004). Schizophrenia: Attitudes of patients and professional carers towards the illness and antipsychotic medication. Pharmacopsychiatry, 37(3), 103-109.
   PubMed Web of Science ®Google Scholar
• Roe, D., Goldblatt, H., Baloush-Kleinman, V., Swarbrick M., & Davidson L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38-46.
   PubMed Web of Science ®Google Scholar
• Rogers, A., Day, J. C., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. P. (1998). The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science and Medicine, 47(9), 1313-1323.
   PubMed Web of Science ®Google Scholar
• Salomon, C., Hamilton, B., & Elsom, S. (2014). Experiencing antipsychotic discontinuation: results from a survey of Australian consumers. Journal of Psychiatric and Mental Health Nursing, 21(10), 917-923. doi: 10.1111 /jpm.12178.
   PubMed Web of Science ®Google Scholar
• Schneider, J. W., & Conrad, P. (1983). Having epilepsy: The experience and control of illness. Philadelphia: Temple University Press.
   Google Scholar
• Suokas, J. T., Suvisaari, J. M., Haukka, J., Korhonen, P., & Tiihonen, J. (2013). Description of long-term polypharmacy among schizophrenia outpatients. Social Psychiatry and Psychiatric Epidemiology, 48(4), 631-638. doi: 10.1007 /s00127-012-0586-6
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Remington, G., Arenovich, T., Uchida, H., Agid, O., Graff-Guerrero, A., & Mamo, D. C. (2011). Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia. British Journal of Psychiatry, 199(4), 275-280. doi: 10.1192 /bjp.bp.110.083907
   PubMed Web of Science ®Google Scholar
• Tiihonen, J., Suokas, J. T., Suvisaari, J. M., Haukka, J., & Korhonen, P. (2012). Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Archives of General Psychiatry, 69(5), 476-483. doi: 10.1001 /archgenpsychiatry.2011.1532
   PubMed Web of Science ®Google Scholar
• Topor, A., Mattsson, M., Denhov, A., Bülow, P., S, H., & L, D. (2012). The Stockholm Follow-up Study of Users Diagnosed with Psychosis (SUPP): Methodology, Patient Cohort and Services. Psychosis, 4(3), 246-257.
   Web of Science ®Google Scholar
• Williams, B., & Calnan, M. (1991). Convergence and divergence: assessing criteria of consumer satisfaction across general practice, dental and hospital care settings. Social Science and Medicine, 33(6), 707–716.
   PubMed Web of Science ®Google Scholar